Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.72 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.58 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.58 |
| ▸ | ITGAL | P20701 | 3/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | GGT1 | P19440 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30081493 | 1.00 | SLC15A2 (0.72) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| SCHEMBL30572128 | 0.91 | SLC15A2 (0.62) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| SCHEMBL29350066 | 0.91 | SLC15A2 (0.62) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| Carnosine SCHEMBL1160796 | 0.89 | SLC15A2 (0.63) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| Carnosine SCHEMBL22392772 | 0.89 | SLC15A2 (0.63) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| Carnosine SCHEMBL1161102 | 0.89 | SLC15A2 (0.63) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| Carnosine SCHEMBL28181512 | 0.88 | ITGB2 (0.65) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| Carnosine SCHEMBL27776508 | 0.88 | SLC15A2 (0.61) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| Carnosine SCHEMBL30129832 | 0.88 | SLC15A2 (0.61) | SLC15A2ITGB2ICAM1ITGALCA1 | |
| Carnosine SCHEMBL28196655 | 0.88 | SLC15A2 (0.61) | SLC15A2ITGB2ICAM1ITGALCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4659592-A1 | FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT | House Foods Corporation (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| US-20250281603-A1 | Compositions for the Treatment of Infectious Disease Related Complications and Methods Thereof | AMARANTUS BIOSCIENCE HOLDINGS (US) | 2025-09-11 | — | — | US | claimed |
| US-20250263437-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) | 2025-08-21 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-119060121-B | Synthesis method of oligopeptide-1 | 山东美欣生物科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| EP-4504166-A1 | TOPICAL FORMULATION FOR USE IN THE TREATMENT OR PREVENTION OF ITCHY DRY SKIN | MC2 Therapeutics Limited (GB) | 2025-02-12 | — | — | EP | claimed |
| EP-4469034-A1 | COMPOSITION FOR TREATING ESOPHAGEAL REFLUX | Metis Healthcare S.r.L. (IT) | 2024-12-04 | — | — | EP | claimed |
| CN-119060121-A | Synthesis process of oligopeptide-1 | 山东美欣生物科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118984702-A | Topical preparation for treating or preventing dry skin itch | MC2疗法有限公司 | 2024-11-19 | — | — | CN | claimed |
| WO-2022074228-A1 | TREATMENT OF DERMATOLOGICAL CONDITIONS | MC2 THERAPEUTICS LTD (GB) | 2022-04-14 | — | — | WO | claimed |
| CN-106573895-B | Novel 5-acylsulfanyl-histidine compounds as precursors for the corresponding 5-sulfanylhistidines and disulfides thereof | 特瑞海德公司 | 2020-11-24 | — | — | CN | claimed |
| CN-106573895-A | Novel 5-acylsulfanyl-histidine compounds as precursors for the corresponding 5-sulfanylhistidines and disulfides thereof | 特瑞海德公司 | 2017-04-19 | — | — | CN | claimed |
| EP-2262521-B1 | OPHTHALMIC COMPOSITIONS COMPRISING A DIPEPTIDE WITH A GLYCINE MOIETY | BAUSCH & LOMB (US) | 2014-02-26 | — | — | EP | claimed |
| US-7977383-B2 | Containing alkali ions, electrolytes, a buffer, polyol, saccharide and hydroxamic acid derivatives | DR. FRANZ KOEHLER CHEMIE GMBH (DE) | 2011-07-12 | — | — | US | claimed |
| EP-2262521-A1 | OPHTHALMIC COMPOSITIONS COMPRISING A DIPEPTIDE | Bausch & Lomb Incorporated (US) | 2010-12-22 | — | — | EP | claimed |
| EP-1859679-B1 | Protective solution for preventing ischaemia damage | KOEHLER CHEMIE DR FRANZ (DE) | 2009-10-28 | — | — | EP | claimed |
| WO-2009120562-A1 | OPHTHALMIC COMPOSITIONS COMPRISING A DIPEPTIDE | BAUSCH & LOMB INCORPORATED (US) | 2009-10-01 | — | — | WO | claimed |
| US-20090247469-A1 | OPHTHALMIC COMPOSITIONS COMPRISING A DIPEPTIDE | BAUSCH HEALTH AMERICAS, INC. | 2009-10-01 | — | — | US | claimed |
| US-20030215781-A1 | Protective solutions for organs | DR. FRANZ KOEHLER CHEMIE GMBH (DE) | 2003-11-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247469-A1 | OPHTHALMIC COMPOSITIONS COMPRISING A DIPEPTIDE | GPKOW, GLMN, ARGLU1 | SLC15A2 3239/4885ITGB2 4012/4885ICAM1 1568/4885 |
| US-20030215781-A1 | Protective solutions for organs | GLS, CA1, SI | SLC15A2 457/4885ITGB2 3782/4885ICAM1 1990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.